
BCG vaccine
1921 · vaccine against tuberculosis developed at the Pasteur Institute
For centuries, tuberculosis was one of the deadliest infectious diseases in Europe and the Americas. It is caused by bacteria and usually affects the lungs, although it can spread to other organs. Before vaccines existed, the options were limited: isolation in sanatoriums, rest, and hoping the body could contain the infection on its own.
In the early twentieth century, the Pasteur Institute in Paris became a key centre for this research. The microbiologist Albert Calmette and the veterinary doctor Camille Guérin started in 1906 from a simple idea: immunity to tuberculosis seemed possible only if the body came into contact with tuberculosis bacilli. To achieve this without causing the disease, they worked with a strain of Mycobacterium bovis, a bacterium normally found in cattle, and weakened it through repeated cultivation. The result is considered the first vaccine against tuberculosis.
The vaccine was first tested in animals. In 1921 it was given to a person for the first time, and the earliest children received it by mouth in the first days of life. Over time, the method of administration changed. From the beginning, however, its effectiveness was debated, since results varied from one place and one trial to another.
A decisive step came in 1974, when the World Health Organization included it in its immunization programme for countries where tuberculosis is endemic. Today it is routinely given in much of the world where the disease is common. Trials in the United Kingdom showed protection of between 60 and 80 percent, while studies elsewhere found no effect at all. A systematic review in 1994 estimated a reduction in the risk of infection of about 50 percent. Its greatest value seems to lie in preventing severe forms such as miliary and meningeal tuberculosis, more than pulmonary disease.
Over time, the bacillus found another use. Since 1977 it has been used to treat superficial bladder cancer: it is placed directly into the bladder and triggers a local immune reaction against the tumour. Recent research has also observed non-specific effects against other infections, which are attributed to a kind of memory in cells of the innate immune system. Even so, it remains the only vaccine licensed against tuberculosis, a disease that is still a major public health problem.
Key dates
- 1906 Calmette and Guérin begin the work at the Pasteur Institute that leads to the vaccine.
- 1921 The vaccine is given to a person for the first time.
- 1974 The WHO adds it to its immunization programme.
- 1977 Its use in treating superficial bladder cancer begins.
- 2021 The centenary of its first human use is marked.
Key figures: Albert Calmette y Camille Guérin
Curiosities and anecdotes
An origin in cattle
The original strain came from a bacterium commonly found in cattle. It was weakened in the laboratory until it could be used safely.
Very long-lasting protection
A study of Native Americans vaccinated in the 1930s found signs of protection even sixty years later, although results from other studies are less consistent.
Sources
Original Medicapedia text based on:
Last updated: 5 November 2026 · How Medicapedia is made
A project by Alejandro Rosàs Navarro, family physician and specialist in preventive medicine and public health. Spotted a mistake? Write to info@medicapedia.org.